OXA-207, a Novel OXA-24 Variant With Reduced Catalytic Efficiency Against Carbapenems in Acinetobacter Pittii From Spain

UDC.coleccionInvestigación
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicas
UDC.endPage4948
UDC.grupoInvInvestigación en Microbiología (INIBIC)
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruña
UDC.issue8
UDC.journalTitleAntimicrobial Agents and Chemotherapy
UDC.startPage4944
UDC.volume58
dc.contributor.authorCayo, Rodrigo
dc.contributor.authorMerino Carballeira, María
dc.contributor.authorRuiz del Castillo, Belén
dc.contributor.authorCano, María E.
dc.contributor.authorGarcía Calvo-Montes, Jorge
dc.contributor.authorBou, Germán
dc.contributor.authorMartínez-Martínez, Luis
dc.date.accessioned2026-09-23T10:27:29Z
dc.date.available2026-09-23T10:27:29Z
dc.date.issued2014-07-15
dc.descriptionBrief report
dc.description.abstract[Abstract] A carbapenem-resistant Acinetobacter pittii strain carrying an OXA-24-like enzyme was isolated in northern Spain in 2008. Sequence analysis confirmed the presence of the novel bla(OXA-207) gene flanked by the site-specific XerC/XerD-like recombination binding sites and showing a unique Gly222Val substitution compared to OXA-24. Cloning and kinetic analysis showed that OXA-207 presents a reduction in the catalytic efficiency against carbapenems and a noticeable increase for oxacillin.
dc.description.sponsorshipThis work was partially supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III - cofinanced by the European Development Regional Fund “A way to achieve Europe” ERDF, the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), and by the Fondo de Investigación Sanitaria (PI080209, PS09/00687, and PI12/00552). We are grateful to the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), which gave a PDEE grant to R.C. (protocol 4149/08-4).
dc.identifier.citationCayô R, Merino M, Ruiz Del Castillo B, Cano ME, Calvo J, Bou G, Martínez-Martínez L. OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain. Antimicrob Agents Chemother. 2014 Aug;58(8):4944-8.
dc.identifier.doi10.1128/AAC.02633-13
dc.identifier.issn1098-6596
dc.identifier.urihttps://hdl.handle.net/2183/49395
dc.language.isoeng
dc.publisherAmerican Society for Microbiology
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RD12%2F0015%2F0002/ES/Enfermedades infecciosas/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN//PS09%2F00687/ES/MECANISMO DE ACCION DE LOS ANTIBIOTICOS EN ACINETOBACTER BAUMANNII Y ESTRES OXIDATIVO: APLICACION AL DIAGNOSTICO RAPIDO DE RESISTENCIAS A ANTIMICROBIANOS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//PI12%2F00552/ES/Estudios preclínicos con D-aminoácidos para atenuar la virulencia de Acinetobacter baumannii y otros patógenos multirresistentes: Una nueva estrategia para erradicar una infección/
dc.relation.urihttps://doi.org/10.1128/AAC.02633-13
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAcinetobacter
dc.subjectAnti-Bacterial Agents
dc.subjectCarbapenems
dc.subjectOxacillin
dc.subjectbeta-Lactamases
dc.titleOXA-207, a Novel OXA-24 Variant With Reduced Catalytic Efficiency Against Carbapenems in Acinetobacter Pittii From Spain
dc.typejournal article
dc.type.hasVersionAM
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cayo_Oxa-207_2014.pdf
Size:
709.31 KB
Format:
Adobe Portable Document Format